Sathyan, A. (2025) “A Comprehensive Review of Evidence and Challenges in Switching from Originator Drugs to Biosimilars of Monoclonal Antibodies: Focus on Rituximab and Trastuzumab”, Journal of Drug Delivery and Therapeutics, 15(2), pp. 149–155. doi:10.22270/jddt.v15i2.7012.